Ligand Pharmaceuticals Inc
SWB:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
SWB:LGDN
|
US |
|
S
|
Silvercorp Metals Inc
AMEX:SVM
|
CA |
|
C
|
Cisco Systems Inc
XBER:CIS
|
US |
|
UniCredit SpA
MIL:UCG
|
IT |
|
B
|
Baxter International Inc
SWB:BTL
|
US |
|
A
|
Amcor PLC
XMUN:485
|
UK |
|
B
|
Brunello Cucinelli SpA
SWB:8BU
|
IT |
|
B
|
Banco de Chile
SWB:G4RA
|
CL |
|
V
|
Volkswagen AG
XHAM:VOW3
|
DE |
|
A
|
Apogee Therapeutics Inc
NASDAQ:APGE
|
US |
|
A
|
Ambev SA
SWB:AMNA
|
BR |
|
Puradelta Lestari Tbk PT
OTC:PTPLF
|
ID |
|
S
|
Sempra
DUS:SE4
|
US |
|
Capri Holdings Ltd
NYSE:CPRI
|
UK |
|
B
|
Beiersdorf AG
SWB:BEI
|
DE |
|
Montrose Environmental Group Inc
NYSE:MEG
|
US |
|
M
|
Mitsubishi UFJ Financial Group Inc
OTC:MBFJF
|
JP |
|
M
|
Mitsubishi UFJ Financial Group Inc
F:MFZ
|
JP |
|
NXP Semiconductors NV
NASDAQ:NXPI
|
NL |
|
Amcor PLC
OTC:AMCCF
|
UK |
|
E
|
Ensign Group Inc
XBER:EGB
|
US |
|
Brookfield Corp
TSX:BN
|
CA |
|
N
|
New China Life Insurance Co Ltd
XBER:NCL
|
CN |
|
R
|
Rhythm Pharmaceuticals Inc
SWB:1RV
|
US |
Bankruptcy Probability
Ligand Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ligand Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
4.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ligand Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ligand Pharmaceuticals Inc has total debt of 446.2m USD. This includes both short-term (0 USD) and long-term (446.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
